SCHEDULE: Jorey Chernett Increases Kazia Therapeutics Stake to 13.9%
Beneficial Ownership Disclosure
Jorey Chernett has reported an increased beneficial ownership of 13.90% in Kazia Therapeutics Ltd, holding 1,588,129 American Depositary Shares.
Summary
- Jorey Chernett beneficially owns 1,588,129 American Depositary Shares (ADS) of Kazia Therapeutics Ltd.
- This ownership represents 13.90% of the company's outstanding American Depositary Shares.
- The percentage is calculated based on 11,426,899 American Depositary Shares outstanding as of March 12, 2026, as disclosed in the Issuer's Form F-3 filed on March 17, 2026.
- The event requiring this Schedule 13G filing occurred on March 24, 2026.
- The Reporting Person certified that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as moderately positive, as a significant individual investor maintaining or increasing a substantial stake suggests confidence in the company's future, without indicating any immediate operational changes.
Positives
- A significant beneficial ownership stake of 13.90% by Jorey Chernett indicates a strong belief in Kazia Therapeutics Ltd's long-term prospects.
- The passive nature of the filing (Schedule 13G) suggests the investor is not seeking to influence control, which can be viewed as a stable, long-term investment.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that significant passive stakes by individual investors, as disclosed in Schedule 13G filings, often signal confidence in a company's long-term value proposition, particularly in sectors like biotechnology where development cycles are extended and capital-intensive.
Stakeholder Impact
- Shareholders: May experience increased confidence due to a significant investor's substantial stake, potentially signaling positive long-term prospects for the company.
Key Dates
| Date | Description |
|---|---|
| 02/19/2026 | Date as of which Jorey Chernett beneficially owned 1,588,129 American Depositary Shares. |
| 03/12/2026 | Date as of which 11,426,899 American Depositary Shares were outstanding, used for percentage calculation. |
| 03/17/2026 | Date of Issuer's Registration Statement on Form F-3 filing with the U.S. Securities and Exchange Commission. |
| 03/24/2026 | Date of event which requires filing of this statement. |
| 03/31/2026 | Date of signature for the Schedule 13G filing. |
Keywords
Kazia Therapeutics, KAZIA, Jorey Chernett, American Depositary Shares, ADS, Beneficial Ownership, SEC Filing, Schedule 13G, Biotechnology, Pharmaceuticals
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.